Learn More
Medchemexpress LLC N-hydroxy-7-(naphthalen-2-ylthio)heptanamide | 926908-04-5 | MFCD10568146 | 99.8% | 303.42 | C17H21NO2S | 50 MG

Supplier: Medchemexpress LLC HY11867250MG
HNHA (N-hydroxy-7-(naphthalen-2-ylthio)heptanamide) is a potent histone deacetylase (HDAC) inhibitor supplied for research use. It induces histone hyperacetylation, arrests the cell cycle at G1/S via p21 induction, and has shown inhibition of tumor growth and tumor neovascularization in preclinical studies.
- Potent HDAC inhibitor (IC50 = 100 nM).
- Induces histone hyperacetylation and p21-mediated G1/S arrest.
- Shown to inhibit tumor growth and tumor neovascularization in preclinical models.
- High purity (99.76%).
- Molecular weight 303.42 Da; formula C17H21NO2S.
- Supplied as a solid with recommended storage at -20°C (powder) and -80°C (in solvent) as applicable.
- For research use only; not for human or veterinary use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.